tetano
Editor, Senior Moderator
J Infect Dis
. 2025 Oct 17;232(Supplement_3):S169-S176.
doi: 10.1093/infdis/jiaf298. Introduction and Update: Advances in Influenza Therapeutics
Frederick G Hayden[SUP] 1 [/SUP], Richard J Whitley[SUP] 2 [/SUP]
Affiliations
This supplement contains 17 articles addressing various aspects of advances in influenza therapeutics and related strategies (e.g., diagnostics, rapid access strategies, and resistance monitoring) for preventing and treating seasonal, zoonotic, and pandemic influenza. In addition to briefly introducing each article, we highlight shortcomings in current use, knowledge gaps requiring further study, and therapeutics of interest entering or advancing in clinical development.
Keywords: Influenza; antibodies; antiviral resistance; antivirals; clinical trials; diagnostic testing; immunomodulators; pandemic; prevention; treatment; zoonotic influenza.
. 2025 Oct 17;232(Supplement_3):S169-S176.
doi: 10.1093/infdis/jiaf298. Introduction and Update: Advances in Influenza Therapeutics
Frederick G Hayden[SUP] 1 [/SUP], Richard J Whitley[SUP] 2 [/SUP]
Affiliations
- PMID: 41102604
- DOI: 10.1093/infdis/jiaf298
This supplement contains 17 articles addressing various aspects of advances in influenza therapeutics and related strategies (e.g., diagnostics, rapid access strategies, and resistance monitoring) for preventing and treating seasonal, zoonotic, and pandemic influenza. In addition to briefly introducing each article, we highlight shortcomings in current use, knowledge gaps requiring further study, and therapeutics of interest entering or advancing in clinical development.
Keywords: Influenza; antibodies; antiviral resistance; antivirals; clinical trials; diagnostic testing; immunomodulators; pandemic; prevention; treatment; zoonotic influenza.